Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL998407 | 0.72 | — | — | |
| SCHEMBL6840576 | 0.65 | — | — | |
| SCHEMBL9497606 | 0.65 | — | — | |
| SCHEMBL2128062 | 0.65 | — | — | |
| SCHEMBL38188 | 0.62 | — | — | |
| SCHEMBL17598891 | 0.62 | — | — | |
| SCHEMBL3261343 | 0.62 | — | — | |
| SCHEMBL10535002 | 0.60 | — | — | |
| Ammonia Solution, Strong SCHEMBL10617791 | 0.60 | — | — | |
| SCHEMBL564758 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119095984-A | Sequencing methods using 3' allyl-terminated nucleotides | 伊路米纳有限公司 | 2024-12-06 | — | — | CN | disclosed |
| US-20050118209-A1 | Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-02 | — | — | US | disclosed |
| US-6372883-B1 | FOR THERAPY AND PROPHYLAXIS OF INFECTIONS CAUSED BY HEPATITIS C, HEPATITIS G AND HUMAN GB VIRUSES | HOFFMANN-LA ROCHE INC. | 2002-04-16 | — | — | US | disclosed |
| US-6018020-A | VIRICIDES WHICH ARE PROTEASE INHIBITORS AGAINST HEPATITIS C AND HEPATITIS G | HOFFMAN-LA ROCHE INC. (US) | 2000-01-25 | — | — | US | disclosed |
| EP-0941233-A2 | ANTIVIRAL PEPTIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1999-09-15 | — | — | EP | disclosed |
| US-5866684-A | Peptidyl inhibitors of viral proteases | HOFFMANN-LA ROCHE INC. (US) | 1999-02-02 | — | — | US | disclosed |
| US-5776902-A | Boronophenyl analogs of phospholyrosines | TRUSTEES OF TUFTS UNIVERSITY (US) | 1998-07-07 | — | — | US | disclosed |
| WO-1998022496-A2 | ANTIVIRAL PEPTIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1998-05-28 | — | — | WO | disclosed |
| US-5580979-A | Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions | TRUSTEES OF TUFTS UNIVERSITY (US) | 1996-12-03 | — | — | US | disclosed |
| WO-1995025118-A2 | INHIBITORS OF SH2 DOMAIN INTERACTIONS | TRUSTEES OF TUFTS UNIVERSITY (US) | 1995-09-21 | — | — | WO | disclosed |
| US-4701545-A | REACTING STERICALLY HINDERED BASE WITH MIXTURE OF DIHALOALKANE AND TRIALKYL BORATE | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1987-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050118209-A1 | Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides | CAT, LPO, GPX4 | ALDH1A1 184/4885TSHR 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.